Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (sar(1),ala(8))angii
2. (sar1,val5,ala8)angiotensin Ii
3. 1 Sar 8 Ala Angiotensin Ii
4. 1 Sarcosine 8 Alanine Angiotensin Ii
5. 1-sar-8-ala Angiotensin Ii
6. 1-sarcosine-8-alanine Angiotensin Ii
7. Angiotensin Ii, 1-sar-8-ala
8. Angiotensin Ii, 1-sarcosine-8-alanine
9. Angiotensin Ii, Sar(1)-ala(8)-
10. Angiotensin Ii, Sarcosyl(1)-alanine(8)-
11. Anhydrous Saralasin Acetate
12. Hydrated Saralasin Acetate
13. Sar-arg-val-tyr-val-his-pro-ala
14. Saralasin
15. Saralasin Acetate, Anhydrous
16. Saralasin Acetate, Hydrated
1. Saralasin Acetate Hydrate
2. Saralasin Acetate [usan]
3. 39698-78-7
4. Saralasin Acetate (usan)
5. Sarenin
6. Unii-fo21z580m4
7. Sarenin (tn)
8. Saralasin Hydrated Acetate
9. Schembl2200145
10. Chembl1200670
11. Fo21z580m4
12. N-(1-(n-(n-(n-(n-(n2-(n-methylglycyl-l-arginyl)-l-l-valyl)-l-tyrosyl)-l-valyl)-l-histidyl)-l-prolyl)-l-alanine Acetate (salt) Hydrate
13. Saralasin Acetate(34273-10-4 Free Base)
14. D04126
15. Q27278095
16. [sar1, Val5, Ala8]-angiotensin Ii Acetate Salt Hydrate, >=97% (hplc), Powder
17. Angiotensin Ii, 1-(n-methylglycine)-5-l-valine-8-l-alanine-, Acetate (salt) Hydrate
18. N-(1-(n-(n-(n-(n-(n(sup 2)-(n-methylglycyl-l-arginyl)-l-valyl)-l-tyrosyl)-l-valyl)-l-histidyl)-l-prolyl)-l-alanine Acetate (salt) Hydrate
| Molecular Weight | 990.1 g/mol |
|---|---|
| Molecular Formula | C44H71N13O13 |
| Hydrogen Bond Donor Count | 14 |
| Hydrogen Bond Acceptor Count | 16 |
| Rotatable Bond Count | 25 |
| Exact Mass | 989.52942937 g/mol |
| Monoisotopic Mass | 989.52942937 g/mol |
| Topological Polar Surface Area | 396 Ų |
| Heavy Atom Count | 70 |
| Formal Charge | 0 |
| Complexity | 1700 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Angiotensin II Type 1 Receptor Blockers
Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS. (See all compounds classified as Angiotensin II Type 1 Receptor Blockers.)
ABOUT THIS PAGE
69
PharmaCompass offers a list of Saralasin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Saralasin manufacturer or Saralasin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Saralasin manufacturer or Saralasin supplier.
PharmaCompass also assists you with knowing the Saralasin API Price utilized in the formulation of products. Saralasin API Price is not always fixed or binding as the Saralasin Price is obtained through a variety of data sources. The Saralasin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A SARENIN manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of SARENIN, including repackagers and relabelers. The FDA regulates SARENIN manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. SARENIN API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A SARENIN supplier is an individual or a company that provides SARENIN active pharmaceutical ingredient (API) or SARENIN finished formulations upon request. The SARENIN suppliers may include SARENIN API manufacturers, exporters, distributors and traders.
SARENIN Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of SARENIN GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right SARENIN GMP manufacturer or SARENIN GMP API supplier for your needs.
A SARENIN CoA (Certificate of Analysis) is a formal document that attests to SARENIN's compliance with SARENIN specifications and serves as a tool for batch-level quality control.
SARENIN CoA mostly includes findings from lab analyses of a specific batch. For each SARENIN CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
SARENIN may be tested according to a variety of international standards, such as European Pharmacopoeia (SARENIN EP), SARENIN JP (Japanese Pharmacopeia) and the US Pharmacopoeia (SARENIN USP).
